Finasteride
PROPECIA, PROSCAR
5-alpha Reductase Inhibitor
NADAC/unit
$0.0412
No Shortage
Tier 1: 83.9%
9 Manufacturers
14 ANDAs
1 INDICATIONS & USAGE Finasteride tablets USP are indicated for the treatment of male pattern hair loss (androgenetic alopecia) in MEN ONLY.
vs. brand PROPECIA: Generic saves up to 100% per unit
Active Shortages
2025-08-19 Discontinuation of the manufacture of the drug product, Teva Pharmaceuticals USA, Inc.
2025-08-19 Discontinuation of the manufacture of the drug product, Teva Pharmaceuticals USA, Inc.
2025-08-19 Discontinuation of the manufacture of the drug product, Teva Pharmaceuticals USA, Inc.
Market Intelligence
2023-03-08 Class II Recall: Accord Healthcare, Inc.
2023-03-08 Class II Recall: Accord Healthcare, Inc.
Generic Manufacturers
ACCORD HEALTHCARE INCALKEM LABORATORIES LTDAUROBINDO PHARMA LTDDR REDDYS LABORATORIES INCDR REDDYS LABORATORIES LTDHETERO LABS LTD UNIT IIIORGANON LLC A SUB OF ORGANON AND COSUN PHARMACEUTICAL INDUSTRIES LTDTEVA PHARMACEUTICALS USA INCZYDUS PHARMACEUTICALS USA INC
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.